UICC’s Technical Fellowships provide cancer professionals the chance to gain new knowledge, skills and techniques in cancer control through short learning visits of two weeks to two months’ duration. This specific fellowship opportunity was originally launched in 1976, and was called the International Cancer Research Technology Transfer awards (ICRETT), and has facilitated knowledge exchange for the last four decades.
The 2026 call for applications will be open from 3 April to 4 June 2026
Fellowship award amounts are calculated by UICC based on the fellowship duration and published scales for living costs and economy flight estimates from the home to host countries. For more information, refer to the application guidelines.
The 2026 call will have a strong emphasis on public health and the training of health professionals on cost-effective and evidence-based cancer control strategies and interventions relevant to and appropriate to the applicant’s context, and the wider health system.
Fellowships on preventing cancer or detecting it early as well as those projects that ensure equitable access to affordable and effective treatment and the supportive and palliative care of cancer survivors are prioritised. UICC particularly welcomes applications aligned with its Business plan and path to 2028, including improving access and health systems for cancer, increasing attention on women’s cancers and lung cancer and advocating for greater people-centred care. In 2026, UICC is specifically encouraging applications related to cervical cancer, particularly projects supporting the introduction or scale-up of access to HPV vaccination.
Fellowship topics will include cancer research, if it is implementation, translational or clinical research that leads directly to improved health and well-being of cancer patients. Applications on purely basic research are not encouraged, with applicants working on these topics encouraged to apply for a YY Study Grant.
UICC prioritizes projects aligned with:
👉 Clear linkage to global cancer control goals is essential
A major distinguishing predictor:
👉 Equity and global impact are central to UICC funding decisions
UICC grants are designed to:
Examples:
👉 This is often more important than pure research output
Successful applications typically include:
👉 North–South and South–South collaborations are highly valued
👉 Overly complex or resource-heavy projects are often rejected
👉 UICC invests in people, not just projects
👉 Impact must be immediate and practical
👉 Overly ambitious budgets reduce chances
Highest impact factors:
Moderate predictors:
4. International collaboration
5. Feasibility in low-resource settings
6. Applicant commitment
Supporting factors:
7. Measurable outcomes
8. Budget clarity
9. Proposal quality
Unlike pharma or EU grants:
👉 Union for International Cancer Control focuses on equity + capacity building over high-end research
Public health professionals including epidemiologists, health educators, social workers, nutritionists, administrators and other specialised professionals working in the field of cancer control; cancer researchers performing translational, clinical and/or implementation research; clinicians, nurses and pathologists.
Application guidelines including the full list of eligibility criteria will be published when the call opens
Sponsor Institute/Organizations: Union for International Cancer Control
Sponsor Type: Corporate/Non-Profit
Address: 31-33 Avenue Giuseppe Motta 1202 Geneva
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jun 04, 2026
Jun 04, 2026
$5,800
Affiliation: Union for International Cancer Control
Address: 31-33 Avenue Giuseppe Motta 1202 Geneva
Website URL: https://www.uicc.org/what-we-do/member-benefits/learning-and-development/fellowships/technical-fellowships
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.